|
|||||
|
|
Re: Phase II Trial of Sorafenib Plus Interferon Alfa-2b as First- or Second-Line Therapy in Patients with Metastatic Renal Cell Cancer |
|
| Authors: | Fray F. Marshall |
| Affiliation: | Department of Urology, Emory University School of Medicine, Atlanta, GA, USA |
| Abstract: | |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ | |